Skip to main content
NVDA-2.45%AAPL+2.59%GOOGL+0.45%MSFT-0.04%AMZN-0.07%TSM-1.20%SPCX+1.15%AVGO-0.54%META-0.77%TSLA-0.64%SKHY-3.86%MU-4.52%BRK-B-0.16%LLY+0.40%JPM-0.53%WMT+0.12%AMD-2.80%V-0.31%XOM+0.85%ASMLa-1.66%JNJ+0.01%INTC-4.89%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.73%ABBV+0.69%BAC-0.47%CSCO-1.32%CVX-0.09%COST-0.15%KO+0.66%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.47%UNH-0.55%HSBA.L-1.30%DELL-3.92%PG+0.14%MS-0.99%GE-0.74%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.02%HD-1.60%0939.HK+1.66%GS-1.00%NZDJPY-2.57%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.38%GBPNZD+1.37%USDJPY-1.22%GBPJPY-1.21%EURJPY-1.20%CADJPY-1.15%NZDCHF-1.03%USDZAR+1.02%USDSEK+0.88%EURZAR+0.87%USDNOK+0.86%AUDNZD+0.80%GBPZAR+0.79%EURSEK+0.73%EURNOK+0.72%AUDCAD-0.68%AUDDKK-0.64%EURAUD+0.61%USDTHB+0.60%AUDUSD-0.58%GBPAUD+0.57%CHFSEK+0.57%CHFNOK+0.55%AUDSGD-0.53%USDMXN+0.44%CADCHF+0.42%USDPLN+0.41%GBPTRY+0.41%NZDSGD-0.40%EURCHF+0.38%USDCHF+0.37%GBPCHF+0.35%NOKJPY-0.34%GBPHKD+0.32%GBPMXN-0.28%SGDJPY+0.26%EURPLN+0.26%USDSGD+0.25%NZDMXN-0.23%AUDCHF-0.22%USDILS+0.16%EURHKD-0.16%USDDKK+0.15%USDTRY+0.11%PLNJPY+0.11%EURSGD+0.11%USDCNH+0.10%EURCZK-0.09%GBPCAD-0.08%AUDNOK+0.07%USDCAD-0.06%CHFSGD-0.06%EURCAD-0.05%USDCOP-0.04%EURGBP+0.03%EURCNH-0.03%GBPSGD+0.02%EURUSD+0.02%USDHKD+0.01%GBPUSD+0.01%EURDKK0.00%XPTUSD-5.82%UKOIL+5.74%USOIL+5.51%GAGUSD-5.16%XAGUSD-5.16%HG1-4.93%GAUUSD-1.33%XAUUSD-1.33%XNGUSD+1.26%S1+0.97%COTTON+0.95%W1+0.92%BTCUSD-1.60%ETHUSD-0.41%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.06%TRXUSDT+0.18%ZECUSDT-8.90%DOGEUSD-3.20%XMRUSDT-0.36%LINKUSD-1.58%XLMUSD-1.64%BCHUSDT-10.50%LTCUSD-2.09%UNIUSD-2.09%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.44%TAOUSDT-5.35%AAVEUSD-2.69%DOTUSDT-2.18%ICPUSDT-2.12%ONDOUSDT-3.45%WLDUSDT-3.15%ATOMUSDT-3.73%ARBUSDT-0.36%JUPUSDT-4.67%INJUSDT-3.45%STXUSDT-3.80%FETUSDT-3.74%TIAUSDT-1.39%PYTHUSDT-1.39%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.69%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.55%IOTAUSDT-4.04%AXSUSDT-2.68%FARTCOINUSDT-4.54%EOSUSDT-3.15%DYDXUSDT-2.64%ORDIUSDT-1.16%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.45%AAPL+2.59%GOOGL+0.45%MSFT-0.04%AMZN-0.07%TSM-1.20%SPCX+1.15%AVGO-0.54%META-0.77%TSLA-0.64%SKHY-3.86%MU-4.52%BRK-B-0.16%LLY+0.40%JPM-0.53%WMT+0.12%AMD-2.80%V-0.31%XOM+0.85%ASMLa-1.66%JNJ+0.01%INTC-4.89%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.73%ABBV+0.69%BAC-0.47%CSCO-1.32%CVX-0.09%COST-0.15%KO+0.66%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.47%UNH-0.55%HSBA.L-1.30%DELL-3.92%PG+0.14%MS-0.99%GE-0.74%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.02%HD-1.60%0939.HK+1.66%GS-1.00%NZDJPY-2.57%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.38%GBPNZD+1.37%USDJPY-1.22%GBPJPY-1.21%EURJPY-1.20%CADJPY-1.15%NZDCHF-1.03%USDZAR+1.02%USDSEK+0.88%EURZAR+0.87%USDNOK+0.86%AUDNZD+0.80%GBPZAR+0.79%EURSEK+0.73%EURNOK+0.72%AUDCAD-0.68%AUDDKK-0.64%EURAUD+0.61%USDTHB+0.60%AUDUSD-0.58%GBPAUD+0.57%CHFSEK+0.57%CHFNOK+0.55%AUDSGD-0.53%USDMXN+0.44%CADCHF+0.42%USDPLN+0.41%GBPTRY+0.41%NZDSGD-0.40%EURCHF+0.38%USDCHF+0.37%GBPCHF+0.35%NOKJPY-0.34%GBPHKD+0.32%GBPMXN-0.28%SGDJPY+0.26%EURPLN+0.26%USDSGD+0.25%NZDMXN-0.23%AUDCHF-0.22%USDILS+0.16%EURHKD-0.16%USDDKK+0.15%USDTRY+0.11%PLNJPY+0.11%EURSGD+0.11%USDCNH+0.10%EURCZK-0.09%GBPCAD-0.08%AUDNOK+0.07%USDCAD-0.06%CHFSGD-0.06%EURCAD-0.05%USDCOP-0.04%EURGBP+0.03%EURCNH-0.03%GBPSGD+0.02%EURUSD+0.02%USDHKD+0.01%GBPUSD+0.01%EURDKK0.00%XPTUSD-5.82%UKOIL+5.74%USOIL+5.51%GAGUSD-5.16%XAGUSD-5.16%HG1-4.93%GAUUSD-1.33%XAUUSD-1.33%XNGUSD+1.26%S1+0.97%COTTON+0.95%W1+0.92%BTCUSD-1.60%ETHUSD-0.41%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.06%TRXUSDT+0.18%ZECUSDT-8.90%DOGEUSD-3.20%XMRUSDT-0.36%LINKUSD-1.58%XLMUSD-1.64%BCHUSDT-10.50%LTCUSD-2.09%UNIUSD-2.09%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.44%TAOUSDT-5.35%AAVEUSD-2.69%DOTUSDT-2.18%ICPUSDT-2.12%ONDOUSDT-3.45%WLDUSDT-3.15%ATOMUSDT-3.73%ARBUSDT-0.36%JUPUSDT-4.67%INJUSDT-3.45%STXUSDT-3.80%FETUSDT-3.74%TIAUSDT-1.39%PYTHUSDT-1.39%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.69%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.55%IOTAUSDT-4.04%AXSUSDT-2.68%FARTCOINUSDT-4.54%EOSUSDT-3.15%DYDXUSDT-2.64%ORDIUSDT-1.16%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
SB

Solid Biosciences Inc. (SLDB)

NASDAQ • Healthcare

$9.53
-$0.39 (-3.9%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$9.77
Previous Close$9.54
Day Range$9.53 - $9.95
Avg. Volume (3M)812.5K
Market Cap$904.7M
52 Week Range
$3.79$11.45
Next EarningsIn 53 daysNov 2, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$207M
EPS (TTM)
-$1.91
ROA (TTM)
-49.24%
Current Ratio
13.82

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+2.0%Q1 2026-$0.5
-30.0%Q2 2026-$0.52
+17.8%Q3 2026-$0.38
Next

Nov 2

in 53 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +17.8%

Solid Biosciences’ loss narrowed versus a year ago in the second fiscal quarter of 2026, with preliminary results reported August 6, 2026 showing GAAP net income of about -$54.8 million, a -38.8% year-over-year move from about -$39.5 million a year ago. On the earnings line, EPS of -$0.38 topped the -$0.46 estimate by $0.08. Profitability remained negative, with operating income of roughly -$57.4 million as the clinical-stage Duchenne muscular dystrophy gene therapy pipeline, including programs such as SGT-001 and SGT-003, continued to drive spending rather than product revenue. Cash usage also stayed elevated, with negative operating cash flow of around -$52.6 million in the quarter. For the next period, consensus calls for EPS of -$0.37.

View full earnings history

About Solid Biosciences Inc.

Solid Biosciences Inc. is a NASDAQ-listed biotechnology company focused on genetic medicines for Duchenne muscular dystrophy. Founded in 2013, the company remains a clinical-stage business rather than a commercial drug maker, with its work centered on developing and advancing neuromuscular gene therapy candidates from Charlestown, Massachusetts.

Name
Solid Biosciences Inc.
CEO
Alexander G. Cumbo
Website
www.solidbio.com
Industry
Healthcare
Year Founded
2013
Employees
121

Today's Snapshot

AI-generated

SLDB is trading 3.5% below yesterday's close, while its sector was flat.

Trading Volume

Below 10d avg (690.1K)

296.1K

vs S&P 500 Today

Underperforming Market

-2.99%

Updated: September 10, 2026 at 17:01 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
SLDB presents a neutral setup marked by mixed moving-average signals: the price around $9.20 sits beneath short-term averages but above longer-term bands, so trend direction is unclear. Momentum and RSI are mildly soft, ADX near 15 indicates little directional strength, and volatility is elevated with ATR about 0.49. Volume readings are contradictory and pivots favor resistance, resulting in limited conviction from momentum and trend indicators. Technical takeaway: Neutral — insufficient trend strength and mixed moving averages produce no clear technical bias.
All signals
  • EMA (5 indicators)$7.57 - $9.74
    Buy
  • RSI (14)46.43
    Neutral
  • Stochastic %K (14, 3, 3)43.90
    Neutral
  • MACD Level (12, 26)0.23
    Neutral

Peers & Related Assets

DSGNDesign Therapeutics, Inc.
$15.02-1.4%
AURAAura Biosciences, Inc.
$7.2-2.2%
ANNXAnnexon, Inc.
$4.37-6.4%
RCKTRocket Pharmaceuticals, Inc.
$3.63-2.2%
QSIQuantum-Si incorporated
$0.75-1.3%
RAPTRAPT Therapeutics, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.